Prognostic significance of surgical margin, Ki-67 and cyclin D1 protein expression in grade II canine cutaneous mast cell tumor

Journal of Veterinary Medical Science

Volumn 69, Issue 11, 2007, Pages 1117-1121

  Ozaki, Kiyokazu ^a   Yamagami, Tetsushi ^b   Nomura, Koji ^b   Narama, Isao ^a  

^a SETSUNAN UNIVERSITY   (Japan)

^b Marupi Lifetech Co Ltd   (Japan)

Author keywords

Canine; Cyclin D1; ki 67; Mast cell tumor; Skin

Indexed keywords

CYCLIN D1; KI 67 ANTIGEN;

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; MASTOCYTOMA; METABOLISM; METASTASIS; PROGNOSIS; RECURRENT DISEASE;

ANIMALS; CYCLIN D1; DOG DISEASES; DOGS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; KI-67 ANTIGEN; MALE; MASTOCYTOMA; NEOPLASM METASTASIS; PROGNOSIS; RECURRENCE;

CANIS FAMILIARIS;

EID: 37049023229     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.69.1117     Document Type: Article

References (27)

1. Abadie, J.J., Amardeilh, M.A. and Delverdier, M.E. 1999. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs. J. Am. Vet. Med. Assoc. 215: 1629-1634.
2. Ayl, R.D., Couto, C.G., Hammer, A.S., Weisbrode, S., Ericson, J.G. and Mathes, L. 1992. Correlation of DNA ploidy to tumor histologic grade, clinical variables, and survival in dogs with mast cell tumors. Vet. Pathol. 29: 386-390.
3. Bostock, D.E. 1973. The prognosis following surgical removal of mastocytomas in dogs. J. Small Anim. Pract. 14: 27-40.
4. Cahalane, A.K., Payne, S., Barber, L.G., Duda, L.E., Henry, C.J., Mauldin, G.E., Frimberger, A.E., Cotter, S.M. and Moore, A.S. 2004. Prognostic factors for survival of dogs with inguinal and perineal mast cell tumors treated surgically with or without adjunctive treatment: 68 cases (1994-2002). J. Am. Vet. Med. Assoc. 225: 401-408.
5. Cangul, I.T., Wijnen, M., Van Garderen, E. and van den Ingh, T.S. 2002. Clinico-pathological aspects of canine cutaneous and mucocutaneous plasmacytomas. J. Vet. Med. A Physiol. Pathol. Clin. Med. 49: 307-312.
6. Colozza, M., Azambuja, E., Cardoso, F., Sotiriou, C., Larsimont, D. and Piccart, M.J. 2005. Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? Ann. Oncol. 16: 1723-1739.
7. Ginn, P.E., Fox, L.E., Brower, J.C., Gaskin, A., Kurzman, I.D. and Kubilis, P.S. 2000. Immunohistochemical detection of p53 tumor-suppressor protein is a poor indicator of prognosis for canine cutaneous mast cell tumors. Vet. Pathol. 37: 33-39.
8. Jaffe, M.H., Hosgood, G., Taylor, H.W., Kerwin, S.C., Hedlund, C.S., Lopez, M.K., Davidson, J.R., Miller, D.M. and Paranjpe, M. 2000. Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumors. Vet. Pathol. 37: 40-46.
9. Kiupel, M., Webster, J.D., Kaneene, J.B., Miller, R. and Yuzbasiyan-Gurkan, V. 2004. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors. Vet. Pathol. 41: 371-377.
10. Kiupel, M., Webster, J.D., Miller, R.A. and Kaneene, J.B. 2005. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours. J. Vet. Med. A Physiol. Pathol. Clin. Med. 52: 280-286.
11. Kravis, L.D., Vail, D.M., Kisseberth, W.C., Ogilvie, G.K. and Volk, L.M. 1996. Frequency of argyrophilic nucleolar organizer regions in fine-needle aspirates and biopsy specimens from mast cell tumors in dogs. J. Am. Vet. Med. Assoc. 209: 1418-1420.
12. Macy, D.W. 1985. Canine mast cell tumors. Vet. Clin. North Am. (Small Anim. Pract.) 15: 783-803.
13. Michels, G.M., Knapp, D.W., DeNicola, D.B., Glickman, N. and Bonney, P. 2002. Prognosis following surgical excision of canine cutaneous mast cell tumors with histopathologically tumor-free versus nontumor-free margins: a retrospective study of 31 cases. J. Am. Anim. Hosp. Assoc. 38: 458-466.
14. Murakami, Y., Tateyama, S., Rungsipipat, A., Uchida, K. and Yamaguchi, R. 2000. Immunohistochemical analysis of cyclin A, cyclin D1 and P53 in mammary tumors, squamous cell carcinomas and basal cell tumors of dogs and cats. J. Vet. Med. Sci. 62: 743-750.
15. Murphy, S., Sparkes, A.H., Smith, K.C., Blunden, A.S. and Brearley, M.J. 2004. Relationships between the histological grade of cutaneous mast cell tumours in dogs, their survival and the efficacy of surgical resection. Vet. Rec. 154: 743-746.
16. O'Keefe, D.A. 1990. Canine mast cell tumors. Vet. Clin. North Am. (Small Anim. Pract.) 20: 1105-1115.
17. Patnaik, A.K., Ehler, W.J. and MacEwen, E.G. 1984. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet. Pathol. 21: 469-474.
18. Preziosi, R., Sarli, G. and Paltrinieri, M. 2004. Prognostic value of intratumoral vessel density in cutaneous mast cell tumors of the dog. J. Comp. Pathol. 130: 143-151.
19. Sakai, H., Noda, A., Shirai, N., Iidaka, T., Yanai, T. and Masegi, T. 2002. Proliferative activity of canine mast cell tumours evaluated by bromodeoxyuridine incorporation and Ki-67 expression. J. Comp. Pathol. 127: 233-238.
20. Seguin, B., Besancon, M.F., McCallan, J.L., Dewe, L.L., Tenwolde, M.C., Wong, E.K. and Kent, M.S. 2006. Recurrence rate, clinical outcome, and cellular proliferation indices as prognostic indicators after incomplete surgical excision of cutaneous grade II mast cell tumors: 28 dogs (1994-2002). J. Vet. Intern. Med. 20: 933-940.
21. Seguin, B., Leibman, N.F., Bregazzi, V.S., Ogilvie, G.K., Powers, B.E., Dernell, W.S., Fettman, M.J. and Withrow, S.J. 2001. Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999). J. Am. Vet. Med. Assoc. 218: 1120-1123.
22. Sfacteria, A., Bertani, C., Costantino, G., Del Bue, M., Paiardini, M., Cervasi, B., Piedimonte, A. and De Vico, G. 2003. Cyclin D1 expression in pre-cancerous and cancerous lesions of the canine mammary gland. J. Comp. Pathol. 128: 245-251.
23. Simoes, J.P.C., Schoning, P. and Butine, M. 1994. Prognosis of canine mast cell tumors: a comparison of three methods. Vet. Pathol. 31: 637-647.
24. Strefezzi Rde, F., Xavier, J.G. and Catao-Dias, J.L. 2003. Morphometry of canine cutaneous mast cell tumors. Vet. Pathol. 40: 268-275.
25. Webster, J.D., Kiupel, M. and Yuzbasiyan-Gurkan, V. 2006. Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors. BMC cancer [electronic resource] 6: 85.
26. Webster, J.D., Yuzbasiyan-Gurkan, V., Kaneene, J.B., Miller, R., Resau, J.H. and Kiupel, M. 2006. The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors. Neoplasia (New York, N.Y) 8: 104-111.
27. Weisse, C., Shofer, F.S. and Sorenmo, K. 2002. Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision. J. Am. Anim. Hosp. Assoc. 38: 71-73.